Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 6, 2024; 12(13): 2275-2280
Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2275
Thymic carcinoid with multiple bone metastases: A case report
Chun-Qiao Chen, Ming-Yue Huang, Min Pan, Qiu-Qiu Chen, Fei-Fei Wei, Hui Huang
Chun-Qiao Chen, Ming-Yue Huang, Min Pan, Qiu-Qiu Chen, Fei-Fei Wei, Hui Huang, Department of Oncology, People’s Hospital of Guilin, Guilin 541000, Guangxi Zhuang Autonomous Region, China
Co-first authors: Chun-Qiao Chen and Ming-Yue Huang.
Author contributions: Chen CQ and Huang H designed the research; Chen CQ, Huang MY, Pan M and Chen QQ performed the research; Wei FF analyzed the data; Chen CQ, Huang MY and Huang H wrote the paper; Chen CQ and Huang MY contributed equally to the manuscript.
Supported by Guangxi Guilin Science and Technology Fund, No. 20190218-7-6.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui Huang, MD, Doctor, Department of Oncology, People’s Hospital of Guilin, No. 12 Wenming Road, Guilin 541000, Guangxi Zhuang Autonomous Region, China. huanghui25002@163.com
Received: December 23, 2023
Peer-review started: December 23, 2023
First decision: January 30, 2024
Revised: February 9, 2024
Accepted: March 28, 2024
Article in press: March 28, 2024
Published online: May 6, 2024
Processing time: 123 Days and 23.8 Hours
Core Tip

Core Tip: Here, we report a 77-year-old man diagnosed with thymic carcinoid (TC) with multiple bone metastases, and the study reports the rapid contraction of thymoid carcinoma after therapy with the multitargeted tyrosine kinase inhibitor anlotinib. The treatment has shown good efficacy, with a long stable disease benefit of more than 2.5 years (until March 2022). These findings demonstrated that anlotinib is a promising treatment regimen for TC tumors with multiple bone metastases.